²é¿´: 1908  |  »Ø¸´: 10

williamxiang

ľ³æ (ÖøÃûдÊÖ)


[½»Á÷] É­ÁÖʵÑéÊÒÁ½¸ö×¼·ÇרÀûÒ©ÎïÓÚÉÏÊкóµÄµÚÒ»¸ö¼¾¶ÈÊ׿ª¼Í¼ ÒÑÓÐ4È˲ÎÓë

¡¡¡¡ÃÀ¹úµÄÉ­ÁÖʵÑéÊÒ£¨Forest Laboratories£©ÓÐÏÞ¹«Ë¾ÓÚµ±µØÊ±¼ä2011Äê10ÔÂ18ÈÕ¹«²¼Á˸ù«Ë¾2012Äê²ÆÕþÄê¶ÈµÚ¶þ¼¾¶È£¨¼´2011ÄêµÚÈý¼¾¶È£©µÄÏúÊÛÒµ¼¨¡£¸ù¾Ý´Ë±¨¸æ£¬¸Ã¹«Ë¾ÆìÏ·ֱðÓÚ½ñÄê1ÔºÍ2Ô»ñµÃFDAÅú×¼ÇÒͬʱÓÚ½ñÄê8Ô¼äÕýʽÉÏÊÐÏúÊ۵Ŀ¹ÒÖÓôÒ©ÎïÑÎËáάÀ­×ôͪºÍÂÞ·úË¾ÌØÓÚËù±¨¸æ¼¾¶ÈÄÚ·Ö±ðʵÏÖÁË850ÍòÃÀÔªÓë120ÍòÃÀÔªµÄÏúÊÛ¶î¡£
¡¡¡¡ÑÎËáάÀ­×ôͪÓÚÖйúÉêÇëµÄ»¯ºÏÎïרÀû¹«¿ªºÅΪCN1106811£¬½«ÓÚ2014Äê9ÔÂ28ÈÕʧЧ£¬µ«¸Ã»¯ÎïËæºóÓÚ2002Äê6ÔÂ5ÈÕÉêÇëÁ˱£»¤ÆäÒ©Óþ§Ð͵ÄÖйúרÀû£¬¹«¿ªºÅΪCN1516699¡£
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
лл·ÖÏí
2Â¥2011-10-20 14:43:35
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

melissa2011

Í­³æ (СÓÐÃûÆø)

¡ï
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
PGxHealth
ÊÇÉ­ÁÖʵÑéÊÒÆìϵģ¿ÉêÇë±£»¤µÄ¾§ÐÍÊÇÉÏÊеľ§ÐͰɣ¿
ÊÀ½çÉÏÓкܶàÊôÓÚÎÒÃǵĶ«Î÷£¬Ö»ÊÇÒª¶®µÃË÷È¡¡£
3Â¥2011-11-25 11:29:06
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

melissa2011

Í­³æ (СÓÐÃûÆø)

¡ï
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
ÑÎËáάÀ­×ôͪ 850ÍòÃÀÔªÊÇÕæµÄô£¿
ÊÀ½çÉÏÓкܶàÊôÓÚÎÒÃǵĶ«Î÷£¬Ö»ÊÇÒª¶®µÃË÷È¡¡£
4Â¥2011-11-25 11:55:55
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

williamxiang

ľ³æ (ÖøÃûдÊÖ)


ÒýÓûØÌû:
4Â¥: Originally posted by melissa2011 at 2011-11-25 11:55:55:
ÑÎËáάÀ­×ôͪ 850ÍòÃÀÔªÊÇÕæµÄô£¿

http://www.frx.com/news/PressRelease.aspx?ID=1618202
You see
5Â¥2011-11-25 12:41:45
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

iamzane

ÖÁ×ðľ³æ (ÖøÃûдÊÖ)

Â¥Ö÷ÊǸöÈÈÐÄÈË
6Â¥2011-11-25 12:47:45
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

melissa2011

Í­³æ (СÓÐÃûÆø)

¡ï
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
ÒýÓûØÌû:
5Â¥: Originally posted by williamxiang at 2011-11-25 12:41:45:
http://www.frx.com/news/PressRelease.aspx?ID=1618202
You see

Following initial trade stocking during the quarter ended June 30, 2011, sales of Daliresp (roflumilast), a PDE4 enzyme inhibitor for the treatment to reduce the risk of exacerbations in patients with chronic obstructive pulmonary disease (COPD) recorded sales of $1.2 million and Viibryd (vilazodone HCl), an SSRI and a partial agonist at serotonergic 5-HT1A receptors for the treatment of MDD recorded sales of $5.3 million.
ÕâÊÇÎÒÕÒµ½µÄÔ­ÎÄ£¬µ«ÊÇÕâÊÇÖ¸ËûµÄÏúÊÛÒµ¼¨Ã´£¿Ôõô¿´ÆðÀ´Êǽ²¹ÉƱµÄÄØ£¿
ÊÀ½çÉÏÓкܶàÊôÓÚÎÒÃǵĶ«Î÷£¬Ö»ÊÇÒª¶®µÃË÷È¡¡£
7Â¥2011-11-25 14:21:39
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

iamzane

ÖÁ×ðľ³æ (ÖøÃûдÊÖ)

¡ï
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
ÊÇ˵ÏúÊÛ£¬²»¹ýÃ²ËÆViibrydÊÇ530w°¡£¬¶ø·Ç850w
8Â¥2011-11-25 14:52:09
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

melissa2011

Í­³æ (СÓÐÃûÆø)

¡ï ¡ï
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
warlen(½ð±Ò+1): лл²ÎÓë 2011-11-26 14:26:19
ÒýÓûØÌû:
8Â¥: Originally posted by iamzane at 2011-11-25 14:52:09:
ÊÇ˵ÏúÊÛ£¬²»¹ýÃ²ËÆViibrydÊÇ530w°¡£¬¶ø·Ç850w

µ«ÊÇ£¬ÎÒÔÚÉ­ÁÖʵÑéÊÒ2011ÄêµÄÄê¶È±¨¸æÉÏ¿´µ½£¬Î¬À­×óͪ2011Äê8Ô²ÅÔÚÃÀ¹úÉÏÊУ¬Õâ¸ö±¨µÀÊÇ2011Äê10Ôµı¨µÀ£¬ÕâÒ²ÂôµÄÌ«ºÃÁ˰ɣ¿
ÊÀ½çÉÏÓкܶàÊôÓÚÎÒÃǵĶ«Î÷£¬Ö»ÊÇÒª¶®µÃË÷È¡¡£
9Â¥2011-11-25 15:00:26
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

melissa2011

Í­³æ (СÓÐÃûÆø)

¡ï
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
ÒýÓûØÌû:
8Â¥: Originally posted by iamzane at 2011-11-25 14:52:09:
ÊÇ˵ÏúÊÛ£¬²»¹ýÃ²ËÆViibrydÊÇ530w°¡£¬¶ø·Ç850w

ºÃ°É£¬È·ÈÏÁËһϣ¬ÊÇ˵µÄÏúÊÛ¶î¡£
ÊÀ½çÉÏÓкܶàÊôÓÚÎÒÃǵĶ«Î÷£¬Ö»ÊÇÒª¶®µÃË÷È¡¡£
10Â¥2011-11-25 15:14:44
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ williamxiang µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼²©] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼± +4 khieu8v8m0 2026-02-22 4/200 2026-02-23 06:46 by jsjzfl
[˶²©¼ÒÔ°] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼± +3 8rmuugja8q 2026-02-22 6/300 2026-02-23 06:39 by w4l55oybr1
[ÂÛÎÄͶ¸å] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼± +3 w89i99eaeh 2026-02-22 4/200 2026-02-23 06:36 by w4l55oybr1
[¹«Åɳö¹ú] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼± +3 khieu8v8m0 2026-02-22 5/250 2026-02-23 06:29 by w4l55oybr1
[˶²©¼ÒÔ°] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼± +4 khieu8v8m0 2026-02-22 8/400 2026-02-23 06:24 by w4l55oybr1
[²©ºóÖ®¼Ò] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼± +6 3dfhjxgsh7 2026-02-22 8/400 2026-02-23 06:21 by w4l55oybr1
[¿¼ÑÐ] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼± +4 usprnugpzw 2026-02-21 10/500 2026-02-23 04:58 by 5jlh3qtdvx
[ÂÛÎÄͶ¸å] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼± +3 khieu8v8m0 2026-02-22 6/300 2026-02-23 02:08 by 5jlh3qtdvx
[¿¼²©] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼± +5 3dfhjxgsh7 2026-02-22 6/300 2026-02-23 02:04 by 5jlh3qtdvx
[½Ìʦ֮¼Ò] °æÃæ·Ñ¸Ã½»Âð +7 Æ»¹ûÔÚÄÄÀï 2026-02-22 8/400 2026-02-22 22:37 by otani
[»ù½ðÉêÇë] »ù½ðÕýÎÄ30Ò³Ö¸µÄÊDZ¨¸æÕýÎÄ»¹ÊÇÕû¸öÉêÇëÊé +5 successhe 2026-02-16 6/300 2026-02-22 21:38 by ɽÎ÷Ðü¿ÕË¿ÕÐüÎ
[½Ìʦ֮¼Ò] ΪʲôÖйú´óѧ½ÌÊÚÃÇË®ÁËÄÇô¶àËùνµÄ¶¥»á¶¥¿¯£¬µ«»¹ÊÇ×ö²»³öÓîÊ÷»úÆ÷ÈË£¿ +5 »¶ÀÖËÌÒ¶Ýè 2026-02-21 5/250 2026-02-22 21:15 by ɽÎ÷Ðü¿ÕË¿ÕÐüÎ
[ÂÛÎÄͶ¸å] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼± +4 usprnugpzw 2026-02-21 6/300 2026-02-22 19:48 by w89i99eaeh
[¿¼ÑÐ] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼± +3 3dfhjxgsh7 2026-02-22 4/200 2026-02-22 16:52 by khieu8v8m0
[ÕÒ¹¤×÷] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼± +3 usprnugpzw 2026-02-22 3/150 2026-02-22 16:37 by khieu8v8m0
[¹«Åɳö¹ú] ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼± +3 usprnugpzw 2026-02-21 4/200 2026-02-22 16:27 by khieu8v8m0
[»ù½ðÉêÇë] ¡°ÈËÎÄÉç¿Æ¶øÂÛ£¬Ðí¶àѧÊõÑо¿»¹Ã»ÓдﵽÃñ¹úʱÆÚµÄˮƽ¡± +4 ËÕ¶«ÆÂ¶þÊÀ 2026-02-18 5/250 2026-02-22 16:07 by liangep1573
[»ù½ðÉêÇë] ʲôÊÇÈËÒ»Éú×îÖØÒªµÄ£¿ +4 ˲ϢÓîÖæ 2026-02-21 4/200 2026-02-22 11:44 by huagongfeihu
[»ù½ðÉêÇë] ½ñÄê´ºÍíÓм¸¸ö½ÚÄ¿ºÜ²»´í£¬µãÔÞ£¡ +11 ˲ϢÓîÖæ 2026-02-16 12/600 2026-02-21 21:14 by lq493392203
[»ù½ðÉêÇë] ÌåÖÆÄÚ³¤±²ËµÌåÖÆÄÚ¾ø´ó²¿·ÖÒ»±²×ÓÔڵײ㣬ÈçͬÄãÃÇÒ»Ñù´ó²¿·ÖÆÕͨ½ÌʦæÇÒÊÕÈëµÍ +9 ˲ϢÓîÖæ 2026-02-20 12/600 2026-02-21 10:39 by »¶ÀÖËÌÒ¶Ýè
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û